Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for LifeMD, Inc. (LFMD : NSDQ)

• Company Description    LifeMD Inc. is a telehealth company. It offers a full portfolio of direct-to-patient products and services. The company combines virtual medical treatment with prescription medications and unique over-the-counter products. Its network of licensed physicians offers telemedicine services and direct-to-consumer pharmacy to consumers. LifeMD Inc., formerly known as Conversion Labs, is based in NEW YORK. Number of Employees: 389

• Price / Volume Information    Yesterday's Closing Price: $4.44 Daily Weekly Monthly 20 Day Moving Average: 1,458,626 shares Shares Outstanding: 47.97 (millions) Market Capitalization: $213.00 (millions) Beta: 1.92 52 Week High: $15.84 52 Week Low: $2.56 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 55.79% 58.74% 12 Week 28.32% 32.03% Year To Date 30.20% 32.71%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 236 FIFTH AVENUE SUITE 400 - NEW YORK,NY 10001 USA ph: 866-351-5907 fax: - ybriggs@allianceadvisors.com http://www.lifemd.com

• General Corporate Information    Officers Justin Schreiber - Chief Executive Officer and Chairman Marc Benathen - Chief Financial Officer Roberto Simon - Director John Strawn - Director Joseph DiTrolio - Director Peer Information LifeMD, Inc. (CHCR) LifeMD, Inc. (ESRX) LifeMD, Inc. (MYDP) LifeMD, Inc. (COR) LifeMD, Inc. (GBCS) LifeMD, Inc. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 53216B104 SIC: 8011 Fiscal Year Fiscal Year End: December Last Reported Quarter: 12/01/25 Next Expected EPS Date: 05/05/26 Share - Related Items Shares Outstanding: 47.97 Most Recent Split Date: 10.00 (0.20:1) Beta: 1.92 Market Capitalization: $213.00 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.14 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.01 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 05/05/26

• Fundamental Ratios P/E Current FY Estimate: 444.00 Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 9.23 Price/Cash Flow: - Price / Sales: 0.91 EPS Growth vs. Year Ago Period: -100.00% vs. Previous Quarter: 60.00% Sales Growth vs. Year Ago Period: -27.06% vs. Previous Quarter: -22.11% ROE 12/31/25 - -83.93 09/30/25 - - 06/30/25 - - ROA 12/31/25 - -7.85 09/30/25 - -6.36 06/30/25 - -8.01 Current Ratio 12/31/25 - 1.25 09/30/25 - 0.73 06/30/25 - 0.77 Quick Ratio 12/31/25 - 1.18 09/30/25 - 0.66 06/30/25 - 0.72 Operating Margin 12/31/25 - -2.37 09/30/25 - -1.82 06/30/25 - -2.41 Net Margin 12/31/25 - 6.58 09/30/25 - -1.82 06/30/25 - -2.41 Pre-Tax Margin 12/31/25 - -5.25 09/30/25 - -3.00 06/30/25 - -3.56 Book Value 12/31/25 - 0.48 09/30/25 - 0.07 06/30/25 - 0.01 Inventory Turnover 12/31/25 - 8.92 09/30/25 - 9.73 06/30/25 - 9.57 Debt-to-Equity 12/31/25 - 0.00 09/30/25 - 0.00 06/30/25 - 9.21 Debt-to-Capital 12/31/25 - 0.00 09/30/25 - 0.00 06/30/25 - 90.20

Powered by Zacks Investment Research ©